| 51 |
20100636 | 17q12-21 - the pursuit of targeted therapy in breast cancer. | 2010 May |
1 |
| 52 |
20130985 | Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer. | 2010 Apr |
2 |
| 53 |
20217261 | Topoisomerase 2 alpha and the case for individualized breast cancer therapy. | 2010 May |
1 |
| 54 |
20464479 | CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D. | 2010 Aug |
1 |
| 55 |
20676126 | Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge. | 2010 Sep 23 |
1 |
| 56 |
18815879 | Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. | 2009 Sep |
1 |
| 57 |
19365520 | Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment. | 2009 Mar |
3 |
| 58 |
19401546 | Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. | 2009 May 6 |
3 |
| 59 |
19401550 | Alterations in the TOP2A and HER2 genes: association with adjuvant anthracycline sensitivity in human breast cancers. | 2009 May 6 |
1 |
| 60 |
19417146 | Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin. | 2009 May |
2 |
| 61 |
19620488 | Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. | 2009 Aug 20 |
1 |
| 62 |
19914538 | Aiming at the target: improved adjuvant medical therapy. | 2009 Oct |
1 |
| 63 |
19996222 | Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. | 2009 Dec 15 |
2 |
| 64 |
20069504 | Evaluation of the predictive value of topoisomerase II alpha in patients with breast carcinoma. | 2009 |
2 |
| 65 |
18258981 | HER-2 and topoisomerase II as predictors of response to chemotherapy. | 2008 Feb 10 |
3 |
| 66 |
18332872 | Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. | 2008 May |
1 |
| 67 |
18413646 | Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques. | 2008 Jul |
1 |
| 68 |
18702822 | Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts. | 2008 Aug 14 |
1 |
| 69 |
19158039 | New understanding of the role of anthracyclines in early-stage breast cancer: patient selection considerations. | 2008 Dec |
1 |
| 70 |
17260090 | Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. | 2007 Dec |
2 |
| 71 |
17453369 | Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations. | 2007 |
1 |
| 72 |
17922046 | HER-2, TOP2A and chromosome 17 alterations in breast cancer. | 2007 |
1 |
| 73 |
16682728 | Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401. | 2006 Jun 1 |
2 |
| 74 |
16864174 | TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer. | 2006 |
1 |
| 75 |
17100565 | Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer. | 2006 Nov |
1 |
| 76 |
15628907 | Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization. | 2005 Jan |
2 |
| 77 |
15891995 | The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study. | 2005 Apr |
1 |
| 78 |
14978790 | Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples. | 2004 Apr |
2 |
| 79 |
15034864 | Gene copy mapping of the ERBB2/TOP2A region in breast cancer. | 2004 May |
1 |